The active vitamin D metabolite, 1,25-dihydroxyvitamin DJ [1,25-(OH)(2)D-3]
, exerts immunosuppressive activity. At a cellular and molecular level, the
hormone preferentially targets helper T cell activity (Th1) by inhibiting
the secretion of both IL-2 and IFN-gamma by Th1 and by suppressing the secr
etion pro-Th1 cytokine IL-12 by antigen-presenting cells. The active metabo
lite further inhibits class II antigen expression and enhances suppressor;a
ctivity,
In animal models of autoimmunity, 1,25-(OH)(2)D-3 prevents the development
of experimental autoimmune encephalomyelitis, reduces the incidence of diab
etes, and attenuates murine lupus. The hormone also prolongs graft survival
in animal models of transplantation.
In humans, non-classical use of 1,25-(OH)(2)D-3 has led to an anti-prolifer
ative effect in psoriasis, antineoplastic effect in prostate cancer, and im
munomodulatory effect in scleroderma. The development of less hypercalcemic
analogs might open a new therapeutic area for vitamin D-3.